Endothelial integrins and angiogenesis: Not so simple anymore

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 913-914

  Sheppard, Dean ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; INTEGRIN; SCLEROPROTEIN;

ANGIOGENESIS; EXTRACELLULAR MATRIX; GENE TARGETING; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0036791465     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216713     Document Type: Note

References (16)

1. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:11-25.
2. Brooks, P.C., et al. 1994. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
3. Brooks, P.C., Clark, R.A., and Cheresh, D.A. 1994. Requirement of vascular integrin αvβ3 for angiogenesis. Science. 264:569-571.
4. Freidlander, M., et al. 1995. Definition of two angiogenic pathways by distinct αv integrins. Science. 270:1500-1502.
5. Kim, S., Bell, K., Mousa, S., and Varner, J.A. 2000. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell binding domain of fibronectin. Am. J. Pathol. 156:1345-1362.
6. Kim, S., Bakre M., Yin, H., and Varner, J.A. 2002. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J. Clin. Invest. 110:933-941. doi: 10.1172/JCI200214268.
7. Yang, J.T., Rayburn, H., and Hynes, R.O. 1993. Embryonic mesodermal defects in α5 integrin-deficient mice. Development. 119:1093-1105.
8. Bader, B.L., Rayburn, H., Crowley, D., and Hynes, R.O. 1998. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell. 95:507-519.
9. Zhu, J., et al. 2002. beta8 integrins are required for vascular morphogenesis in mouse embryos. Development. 129:2891-2903.
10. Hodivala-Dilke, K.M., et al. 1999. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:229-238.
11. Huang, X.Z., Griffiths, M., Wu, J.F., Farese, R.F., Jr., and Sheppard, D. 2000. Impaired cell migration and adhesion but normal development in β5 deficient mice. Mol. Cell. Biol. 20:755-759.
12. Reynolds, L.E., et al. 2002. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat. Med. 8:27-34.
13. Frisch, S.M., and Francis, H. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
14. Meredith, J.E., Jr., Fazeli, B., and Schwartz, M.A. 1993. The ECM as a cell survival factor. Mol. Biol. Cell. 4:953-961.
15. Stupack, D.G., Puente, X.S., Boutsaboualoy, S., Storgard, C.M., and Cheresh, D.A. 2001. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155:459-470.
16. Hood, J.D., et al. 2002. Tumor regression by targeted gene delivery to the neovasculature. Science. 296:2404-2407.